Immix Biopharma
preclinical data in breast cancer immix therapies produce rare tumor shrinkage stability | Immix Biopharma
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
52 of 61
Similar slides by Immix Biopharma
See diffirences between slides (animation)
Investor Presentation
January 2024
preclinical data in breast cancer immix therapies produce rare tumor shrinkage stability | Immix Biopharma
Investor Presentation
December 2023
preclinical data in breast cancer immix therapies produce rare tumor shrinkage stability | Immix Biopharma
Investor Presentation
November 2023
preclinical data in breast cancer immix therapies produce rare tumor shrinkage stability | Immix Biopharma
Investor Presentation
November 2023
preclinical data in breast cancer immix therapies produce rare tumor shrinkage stability | Immix Biopharma
Related slides by other companies
Exscientia
Results
November 2023
inhibits model growth in | Exscientia
Exscientia
Investor Presentation
March 2024
inhibits model growth in | Exscientia
Exscientia
Investor Day
January 2024
inhibits model growth in | Exscientia
Imara
Mergers and Acquisitions
October 2022
demonstrated robust anti tumor activity in her model at well tolerated doses | Imara
Other recent decks by Immix Biopharma
See all presentations (11 decks)
Investor Presentation
March 2024
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io